SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
SPI-62-CL-2002
Phase 2 other active
Quick answer
SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor for Hypercortisolism related to benign adrenal tumour is a Phase 2 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Hypercortisolism related to benign adrenal tumour
- Phase
- Phase 2
- Modality
- other
- Status
- active